Ea. Kopecky et al., CORRELATION OF MORPHINE-SULFATE IN BLOOD-PLASMA AND SALIVA IN PEDIATRIC-PATIENTS, Therapeutic drug monitoring, 19(5), 1997, pp. 530-534
This study sought to determine whether saliva concentrations of morphi
ne correlate with plasma levels of morphine in pediatric patients rece
iving morphine analgesia for severe pain, and to evaluate whether the
measurement of saliva morphine concentrations would be a useful, nonin
vasive, clinical tool to diagnose systemic exposure to morphine. Fifte
en pediatric patients were enrolled. for the control group, 18 adult v
olunteers were recruited. Patients received continuous morphine drips
to ameliorate pain caused by a sickle cell vasoocclusive crisis (range
, 10-40 mu g/kg.h). Control subjects were randomized into those receiv
ing acetaminophen with either 8 mg (n = 13) or 30 mg (it = 5) of codei
ne. All participants fasted at least 2 hours before sample collection.
Blood and saliva samples were collected simultaneously. All samples w
ere analyzed by radioimmunoassay for morphine. There was no correlatio
n between saliva and plasma morphine concentrations in either the pati
ents receiving intravenous morphine (r = 0.04, P = 0.89) or in the con
trols receiving codeine (r = 0.43, P = 0.08). There was no observed di
fference in the mean counts per minute (CPM) for saliva samples in the
pH range 3.96 to 8.06. Saliva concentrations of morphine cannot be us
ed to predict the plasma concentration of morphine in children or adul
ts. However, the concentration of morphine in saliva may be used as a
qualitative indicator of systemic exposure to morphine in a subject.